The bidirectional Thymus-Gut Axis: redefining central tolerance in digestive autoimmunity

Digestive autoimmune diseases impose an escalating global burden, largely because current therapies predominantly target downstream inflammation rather than primordial defects in immune tolerance. The thymus establishes central tolerance through stringent T cell selection and thymus-derived regulatory T cell (tTreg) generation. This review proposes the Thymus-Gut Axis as a working conceptual framework for a dynamic, bidirectional communication network, departing from the traditional unidirectional thymocentric model, while explicitly acknowledging that much of the supporting evidence remains indirect, model-dependent, or derived from broader thymus-microbiota studies rather than from human digestive autoimmunity. We elucidate how thymic dysfunction-driven by defective negative selection, impaired tTreg generation, and AIRE/FEZF2-mediated antigen presentation defects-precipitates the escape of autoreactive clones that drive specific digestive autoimmunity. Conversely, we highlight the hypothetical retrograde signaling arm, wherein gut-derived microbial metabolites, inflammatory cytokines, and migratory dendritic cells have been shown, primarily in murine models, to modulate the thymic microenvironment. However, direct validation in human digestive autoimmunity is currently lacking, and the translational relevance of these findings remains uncertain. Furthermore, sex steroids and early-life microbiota critically program central tolerance, shaping sex-biased susceptibility and lifelong immune homeostasis. Translating these mechanistic insights, we evaluate thymectomy as a clinical model, emerging thymic rejuvenation strategies, and antigen-specific therapeutic Treg therapies. Ultimately, we emphasize the urgent need for human thymic profiling and longitudinal clinical studies integrating systemic thymic output biomarkers with mucosal immune phenotyping to bridge translational gaps and explore speculative but mechanistically rational therapeutic strategies.

Authors

Institutions

Publication Details

Journal
Molecular Medicine
Published
2026-08-03
DOI
https://doi.org/10.1186/s10020-026-01588-0
Primary Topic
T-cell and B-cell Immunology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The bidirectional Thymus-Gut Axis: redefining central tolerance in digestive autoimmunity

张明新, Yang Yang, Shiming Zhou
Molecular Medicine
T-cell and B-cell Immunology
article

The bidirectional Thymus-Gut Axis: redefining central tolerance in digestive autoimmunity

张明新, Yang Yang, Shiming Zhou
article en

Abstract

Digestive autoimmune diseases impose an escalating global burden, largely because current therapies predominantly target downstream inflammation rather than primordial defects in immune tolerance. The thymus establishes central tolerance through stringent T cell selection and thymus-derived regulatory T cell (tTreg) generation. This review proposes the Thymus-Gut Axis as a working conceptual framework for a dynamic, bidirectional communication network, departing from the traditional unidirectional thymocentric model, while explicitly acknowledging that much of the supporting evidence remains indirect, model-dependent, or derived from broader thymus-microbiota studies rather than from human digestive autoimmunity. We elucidate how thymic dysfunction-driven by defective negative selection, impaired tTreg generation, and AIRE/FEZF2-mediated antigen presentation defects-precipitates the escape of autoreactive clones that drive specific digestive autoimmunity. Conversely, we highlight the hypothetical retrograde signaling arm, wherein gut-derived microbial metabolites, inflammatory cytokines, and migratory dendritic cells have been shown, primarily in murine models, to modulate the thymic microenvironment. However, direct validation in human digestive autoimmunity is currently lacking, and the translational relevance of these findings remains uncertain. Furthermore, sex steroids and early-life microbiota critically program central tolerance, shaping sex-biased susceptibility and lifelong immune homeostasis. Translating these mechanistic insights, we evaluate thymectomy as a clinical model, emerging thymic rejuvenation strategies, and antigen-specific therapeutic Treg therapies. Ultimately, we emphasize the urgent need for human thymic profiling and longitudinal clinical studies integrating systemic thymic output biomarkers with mucosal immune phenotyping to bridge translational gaps and explore speculative but mechanistically rational therapeutic strategies.

Molecular Medicine
Xi'an Medical University (CN), Beijing Tsinghua Chang Gung Hospital (CN)
Good health and well-being
Openalex Percentile: Top 15%
T-cell and B-cell Immunology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.